Lucid Diagnostics earnings were -$70.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LUCD earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$36.0M, up 212.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LUCD reported annual earnings of -$53.0M, with 0.7% growth. The next LUCD earnings date is Aug 18, 2025.
What were Lucid Diagnostics's earnings last quarter?
On LUCD's earnings call on Invalid Date, Lucid Diagnostics (NASDAQ: LUCD) reported Q1 2025 earnings per share (EPS) of -$0.52, up 30% year over year. Total LUCD earnings for the quarter were -$36.02 million. In the same quarter last year, Lucid Diagnostics's earnings per share (EPS) was -$0.40.
The next LUCD earnings call is Invalid Date. Add LUCD to your watchlist to be reminded of Lucid Diagnostics's next earnings date.
Is Lucid Diagnostics profitable or losing money?
As of the last Lucid Diagnostics earnings report, Lucid Diagnostics is currently losing money. Lucid Diagnostics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$61.83 million, a 31.46% increase year over year.
What was LUCD's earnings growth in the past year?
As of Lucid Diagnostics's earnings date in Invalid Date, Lucid Diagnostics's earnings has grown year over year. LUCD earnings in the past year totalled -$70.94 million.
What are Lucid Diagnostics's earnings expectations?
The current EPS estimate for Lucid Diagnostics's earnings report in Invalid Date is -$0.11.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.